title: Re: Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization.
authors: Department of Diagnostic and Molecular Imaging, Radiation Therapy and Interventional Radiology, University Hospital Tor Vergata, Viale Oxford 88, 001133 Rome, Italy.
authors: Fabrizio
authors: F
authors: Chegai
authors: Department of Diagnostic and Molecular Imaging, Radiation Therapy and Interventional Radiology, University Hospital Tor Vergata, Viale Oxford 88, 001133 Rome, Italy.
authors: Stefano
authors: S
authors: Merolla
authors: Department of Diagnostic and Molecular Imaging, Radiation Therapy and Interventional Radiology, University Hospital Tor Vergata, Viale Oxford 88, 001133 Rome, Italy.
authors: Laura
authors: L
authors: Greco
authors: Department of Diagnostic and Molecular Imaging, Radiation Therapy and Interventional Radiology, University Hospital Tor Vergata, Viale Oxford 88, 001133 Rome, Italy.
authors: Marco
authors: M
authors: Nezzo
authors: Department of Radiology, Memorial Sloan-Kettering Cancer, New York, New York.
authors: Lorenzo
authors: L
authors: Mannelli
authors: Department of Diagnostic and Molecular Imaging, Radiation Therapy and Interventional Radiology, University Hospital Tor Vergata, Viale Oxford 88, 001133 Rome, Italy.
authors: Antonio
authors: A
authors: Orlacchio
mesh_terms: D000903:Antibiotics, Antineoplastic; D006528:Carcinoma, Hepatocellular; D016461:Chemoembolization, Therapeutic; D004317:Doxorubicin; D006801:Humans; D008113:Liver Neoplasms; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin